Your browser doesn't support javascript.
loading
Treatment Sequencing Survival Model for Patients with Multiple Myeloma Ineligible for Stem Cell Transplantation (SCT).
Heeg, B; Van Agthoven, M; van Beurden-Tan, C; Liwing, J; Mellqvist, U H; Plesner, T; Logman, F; Aschan, J; Einsele, H; Treur, M; Barendse, M; Richardson, P G; Palumbo, A; Nahi, H; Sonneveld, P.
Afiliação
  • Heeg B; Pharmerit International, Rotterdam, The Netherlands.
  • Van Agthoven M; Janssen-Cilag BV, Tilburg, The Netherlands.
  • van Beurden-Tan C; Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Liwing J; Janssen-Cilag AB, Sollentuna, Sweden.
  • Mellqvist UH; Department of Hematology, Gothenburg, Sweden.
  • Plesner T; Vejle Hospital, Vejle, Denmark.
  • Logman F; Eastbridge Pharma BV, Utrecht, The Netherlands.
  • Aschan J; Janssen-Cilag AB, Sollentuna, Sweden.
  • Einsele H; Medizinische Klinik II, Würzburg, Germany.
  • Treur M; Pharmerit International, Rotterdam, The Netherlands.
  • Barendse M; Janssen-Cilag AB, Sollentuna, Sweden.
  • Richardson PG; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Palumbo A; University of Torino, Torino, Italy.
  • Nahi H; Karolinska University Hospital, Solna, Sweden.
  • Sonneveld P; Erasmus University Medical Center, Rotterdam, The Netherlands.
Value Health ; 17(7): A617-8, 2014 Nov.
Article em En | MEDLINE | ID: mdl-27202167
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article